Butuo Li

547 total citations
38 papers, 344 citations indexed

About

Butuo Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Butuo Li has authored 38 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Butuo Li's work include Lung Cancer Research Studies (16 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Butuo Li is often cited by papers focused on Lung Cancer Research Studies (16 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Butuo Li collaborates with scholars based in China, Australia and United Kingdom. Butuo Li's co-authors include Linlin Wang, Bing Zou, Xindong Sun, Jinming Yu, Shijiang Wang, Xindong Sun, Wanlong Li, Linlin Yang, Peng Xie and Haiyan Zeng and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Butuo Li

31 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Butuo Li China 12 204 161 74 57 53 38 344
Joaquín Mosquera Spain 12 305 1.5× 226 1.4× 53 0.7× 55 1.0× 33 0.6× 39 457
Sarah Caulfield United States 11 235 1.2× 163 1.0× 61 0.8× 18 0.3× 66 1.2× 42 353
Susan Percy Ivy United States 6 200 1.0× 78 0.5× 89 1.2× 34 0.6× 47 0.9× 10 414
Yuzuru Watanabe Japan 10 165 0.8× 150 0.9× 61 0.8× 58 1.0× 38 0.7× 24 356
Yongling Ji China 11 161 0.8× 130 0.8× 68 0.9× 45 0.8× 93 1.8× 33 323
Gilles Quéré France 11 314 1.5× 290 1.8× 62 0.8× 96 1.7× 72 1.4× 37 492
Jinan Ma China 12 174 0.9× 101 0.6× 143 1.9× 36 0.6× 42 0.8× 43 397
Ji Hyun Park South Korea 8 123 0.6× 146 0.9× 62 0.8× 26 0.5× 60 1.1× 22 307
Valentina Tateo Italy 10 205 1.0× 150 0.9× 114 1.5× 31 0.5× 106 2.0× 36 437
Dariusz Dziedzic Poland 10 110 0.5× 187 1.2× 40 0.5× 42 0.7× 50 0.9× 32 339

Countries citing papers authored by Butuo Li

Since Specialization
Citations

This map shows the geographic impact of Butuo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Butuo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Butuo Li more than expected).

Fields of papers citing papers by Butuo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Butuo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Butuo Li. The network helps show where Butuo Li may publish in the future.

Co-authorship network of co-authors of Butuo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Butuo Li. A scholar is included among the top collaborators of Butuo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Butuo Li. Butuo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
He, Junyi, Xiaoqing Wang, Jingze Zhang, et al.. (2025). The Impact of Radiation Dose to Immune Cells in Stage IV Non-Small Cell Lung Cancer in the Era of Immunotherapy. Clinical Lung Cancer. 26(3). 221–227.e1.
3.
4.
Zhong, Xiao, Butuo Li, Linlin Yang, et al.. (2025). Incidence and risk factors of pneumonitis in ALK-rearranged non-small cell lung cancer patients treated with alectinib and thoracic radiotherapy. Translational Lung Cancer Research. 14(7). 2723–2735.
5.
Li, Butuo, Bing Zou, Shijiang Wang, et al.. (2025). Deep learning for survival prediction in triple-negative breast cancer: development and validation in real-world cohorts. Scientific Reports. 15(1). 30248–30248.
6.
Yang, Linlin, Butuo Li, Taotao Dong, & Linlin Wang. (2024). ViTR-SP: A CT-based vision transformer model for prediction of pneumonitis in patients with non-small cell lung cancer who received thoracic radiotherapy and immunotherapy.. Journal of Clinical Oncology. 42(16_suppl). e20034–e20034. 1 indexed citations
7.
Chen, Dawei, Bing Zou, Butuo Li, et al.. (2024). Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial. EClinicalMedicine. 75. 102795–102795. 13 indexed citations
8.
9.
Li, Fuyan, Yi Cui, Xiao Wang, et al.. (2023). Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR images. Journal of Magnetic Resonance Imaging. 58(5). 1624–1635. 11 indexed citations
10.
Li, Butuo, Linlin Yang, Huan Zhang, et al.. (2023). Outcome-Supervised Deep Learning on Pathologic Whole Slide Images for Survival Prediction of Immunotherapy in Patients with Non–Small Cell Lung Cancer. Modern Pathology. 36(8). 100208–100208. 5 indexed citations
11.
Fan, Bingjie, Butuo Li, Haoqian Li, et al.. (2023). Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs. Cancer Management and Research. Volume 15. 351–362. 4 indexed citations
12.
Li, Butuo, et al.. (2023). Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab. Frontiers in Oncology. 13. 1052147–1052147. 3 indexed citations
13.
Cui, Hui, Butuo Li, Bing Zou, et al.. (2023). Integrating Preoperative Computed Tomography and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Squamous Cell Carcinoma by Feature-Wise Attentional Graph Neural Network. International Journal of Radiation Oncology*Biology*Physics. 116(3). 676–689. 7 indexed citations
14.
Li, Butuo, Chao Jiang, Xinyu Fan, et al.. (2022). Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer. BMC Cancer. 22(1). 828–828. 6 indexed citations
15.
Li, Butuo, Chao Jiang, Bing Zou, et al.. (2021). Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review. Frontiers in Immunology. 12. 627197–627197. 21 indexed citations
16.
Li, Butuo, Ruiqing Wang, Bing Zou, et al.. (2020). <p>Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer</p>. OncoTargets and Therapy. Volume 13. 9043–9057. 10 indexed citations
17.
Zhang, Dai, Butuo Li, Bing Zou, et al.. (2020). Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy. Lung Cancer. 151. 39–43. 14 indexed citations
18.
Li, Butuo, Ruiqing Wang, Ting Zhang, et al.. (2020). Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases. Scientific Reports. 10(1). 11259–11259. 15 indexed citations
19.
Li, Butuo, et al.. (2018). Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review. Cancer Management and Research. Volume 10. 1461–1470. 32 indexed citations
20.
Wang, Shijiang, et al.. (2018). BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review. Targeted Oncology. 13(4). 517–523. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquín Mosquera Breakdown of academic impact, for papers by Sarah Caulfield Breakdown of academic impact, for papers by Susan Percy Ivy Breakdown of academic impact, for papers by Yuzuru Watanabe Breakdown of academic impact, for papers by Yongling Ji Breakdown of academic impact, for papers by Gilles Quéré Breakdown of academic impact, for papers by Jinan Ma Breakdown of academic impact, for papers by Ji Hyun Park Breakdown of academic impact, for papers by Valentina Tateo Breakdown of academic impact, for papers by Dariusz Dziedzic
Rankless by CCL
2026